We're #hiring a new Associate Director / Director - CMC (Chemistry, Manufacturing, and Controls) in Brisbane, California. Apply today or share this post with your network.
Mammoth Biosciences
Biotechnology Research
Brisbane, California 48,863 followers
Improving lives by reading and writing the code of life.
About us
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company’s ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth’s deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.
- Website
-
http://www.mammoth.bio
External link for Mammoth Biosciences
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Brisbane, California
- Type
- Privately Held
- Founded
- 2017
Locations
-
Primary
1000 Marina Blvd
Suite 600
Brisbane, California 94005, US
Employees at Mammoth Biosciences
Updates
-
We're #hiring a new Director/Senior Director, Regulatory Affairs, Therapeutics in Brisbane, California. Apply today or share this post with your network.
-
Mammoth Biosciences is proud to be one of the finalists in the Emerging Innovation category of the California Life Sciences (CLS) Pantheon Awards. These awards celebrate the achievements of life science innovators, and it's an honor to be recognized for our work with ultracompact #CRISPR to change lives through in vivo gene editing. The final winner will be determined by a public vote. Voting is quick and easy, so come and support Mammoth! https://lnkd.in/ewrA47BB #pantheonawards
-
Our SVP, Legal (Head of IP), Rachel Herder will be speaking at the annual Dr. E. Arthur Dreskin Distinguished Endowed Lecture on Thursday, Sept. 26, at the University of South Carolina School of Medicine Greenville. She'll discuss #CRISPR, and the implications of gene editing. Learn more and see the live-stream here: https://lnkd.in/gyh9GrMi
An upcoming talk at SOMG on the potential of gene editing will be open to the public and live-streamed. We will host our annual Dr. E. Arthur Dreskin Distinguished Endowed Lecture on Sept. 26. Dr. Rachel Herder, Vice President of Intellectual Property at Mammoth Biosciences, will speak about gene editing and the implications of the technology. “The University of South Carolina School of Medicine Greenville is excited to welcome Dr. Herder to explore this innovative technology and … discuss the complexities and some of the ethical issues associated with CRISPR and genome editing,” says Dr. Phyllis MacGilvray, Dean of the School of Medicine Greenville. Read more here >> https://lnkd.in/e9acFnzX
-
Did you miss our Co-Founder & CSO, Lucas Harrington at hashtag #WMIF2024? He's on his way to DC for the ASGCT Summit Policy, #ASGCTadvocacy, catch him as he discusses "Hot Topics in Clinical Development: Risk-Benefit Analysis for Cell and Gene Therapies" with Timothy J. Miller, Ph.D. (he/him), Lisa Martin, and another guest, moderated by Daniela Drago. #CRISPR
-
Our Co-Founder and CSO, Lucas Harrington will be at #WMIF2024 today, speaking on the "Deep Dive on Genetic Modalities for Rare Disease: Genetic Medicines Are Here" panel, with Faraz Ali, Raju Prasad, Sandi See Tai, moderated by Patricia Musolino M.D, Ph.D and Tazeen Ahmad https://lnkd.in/gTWyZa3i #CRISPR #WMIF2024
-
We're #hiring a new Sr. Scientist I/II or Principal Scientist I - CRISPR Gene Off-Targeting Specificity in Brisbane, California. Apply today or share this post with your network.
-
We're #hiring a new Scientist I - Epigenetic Editing Technologies in Brisbane, California. Apply today or share this post with your network.
-
We're #hiring a new Senior Scientist I/II - Epigenetic Editing Technologies in Brisbane, California. Apply today or share this post with your network.
-
We're #hiring a new Associate Director / Director - CMC (Chemistry, Manufacturing, and Controls) in Brisbane, California. Apply today or share this post with your network.